R H Ehrensing. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, OralAnimalsAntipsychotic Agents/adverse effectsCarbonates/administration & dosageCarbonates/therapeutic useDepression/drug therapyDoxepin/administration & dosageDoxepin/therapeutic useDrug Therapy, CombinationFemaleHumansLithium/administration & dosageLithium/therapeutic useMelanocyte-Stimulating Hormones/antagonists & inhibitorsMiddle AgedMovement Disorders/chemically inducedMovement Disorders/drug therapyOligopeptides/therapeutic usePhenothiazinesPituitary Hormone-Releasing Hormones/antagonists & inhibitorsRatsRemission, Spontaneous
Substances： See more » Antipsychotic AgentsCarbonatesOligopeptidesPhenothiazinesPituitary Hormone-Releasing HormonesDoxepinMelanocyte-Stimulating HormonesLithium
Year: 1974 PMID： 4140382 DOI： 10.1016/s0140-6736(74)90127-5
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321